142 related articles for article (PubMed ID: 29252038)
1. Quality-by-design approach for the development of telmisartan potassium tablets.
Oh GH; Park JH; Shin HW; Kim JE; Park YJ
Drug Dev Ind Pharm; 2018 May; 44(5):837-848. PubMed ID: 29252038
[TBL] [Abstract][Full Text] [Related]
2. QbD Consideration for Developing a Double-Layered Tablet into a Single-Layered Tablet with Telmisartan and Amlodipine.
Kim JE; Park YJ
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214109
[TBL] [Abstract][Full Text] [Related]
3. Implementation of Quality by Design for Formulation of Rebamipide Gastro-retentive Tablet.
Ha JM; Seo JW; Kim SH; Kim JY; Park CW; Rhee YS; Park ES
AAPS PharmSciTech; 2017 Nov; 18(8):3129-3139. PubMed ID: 28526986
[TBL] [Abstract][Full Text] [Related]
4. Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo
Lee AR; Kwon SY; Choi DH; Park ES
Int J Pharm; 2017 Dec; 534(1-2):144-158. PubMed ID: 29031980
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of telmisartan tablets prepared via the wet granulation method and pritor™ prepared using the spray-drying method.
Park J; Park HJ; Cho W; Cha KH; Yeon W; Kim MS; Kim JS; Hwang SJ
Arch Pharm Res; 2011 Mar; 34(3):463-8. PubMed ID: 21547679
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
7. An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine.
Mishra SM; Rohera BD
Pharm Dev Technol; 2017 Nov; 22(7):889-903. PubMed ID: 27346282
[TBL] [Abstract][Full Text] [Related]
8. HIGH SHEAR GRANULATION PROCESS: ASSESSING IMPACT OF FORMULATION VARIABLES ON GRANULES AND TABLETS CHARACTERISTICS OF HIGH DRUG LOADING FORMULATION USING DESIGN OF EXPERIMENT METHODOLOGY.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Ali BE
Acta Pol Pharm; 2017 Mar; 74(2):551-564. PubMed ID: 29624260
[TBL] [Abstract][Full Text] [Related]
9. Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools.
Saydam M; Takka S
Drug Dev Ind Pharm; 2018 Dec; 44(12):1905-1917. PubMed ID: 29969042
[TBL] [Abstract][Full Text] [Related]
10. Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach.
Chudiwal VS; Shahi S; Chudiwal S
Drug Dev Ind Pharm; 2018 May; 44(5):787-799. PubMed ID: 29198152
[TBL] [Abstract][Full Text] [Related]
11. Immediate release tablets of telmisartan using superdisintegrant-formulation, evaluation and stability studies.
Sekar V; Chellan VR
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):575-7. PubMed ID: 18379110
[TBL] [Abstract][Full Text] [Related]
12. Co-milling of telmisartan with poly(vinyl alcohol)--An alkalinizer free green approach to ensure its bioavailability.
Isaac J; Ganguly S; Ghosh A
Eur J Pharm Biopharm; 2016 Apr; 101():43-52. PubMed ID: 26829378
[TBL] [Abstract][Full Text] [Related]
13. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
14. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
Rasool BK; Fahmy SA; Galeel OW
Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
[TBL] [Abstract][Full Text] [Related]
15. Development of stabilized tenofovir disoproxil tablet: degradation profile, stabilization, and bioequivalence in beagle dogs.
Oh GH; Kim JE; Park YJ
Drug Dev Ind Pharm; 2018 May; 44(5):757-766. PubMed ID: 29198140
[TBL] [Abstract][Full Text] [Related]
16. Development and Optimization by Quality by Design Strategies of Frovatriptan Orally Disintegrating Tablets for Migraine Management.
Mennini N; Orlandini S; Furlanetto S; Pasquini B; Mura P
Curr Drug Deliv; 2018; 15(3):436-445. PubMed ID: 28595529
[TBL] [Abstract][Full Text] [Related]
17. Development of Bilayer Tablets with Modified Release of Selected Incompatible Drugs.
Dhiman N; Awasthi R; Jindal S; Khatri S; Dua K
Polim Med; 2016; 46(1):5-15. PubMed ID: 28397414
[TBL] [Abstract][Full Text] [Related]
18. Implementation of quality by design approach in manufacturing process optimization of dry granulated, immediate release, coated tablets - a case study.
Teżyk M; Jakubowska E; Milanowski B; Lulek J
Drug Dev Ind Pharm; 2017 Oct; 43(10):1626-1636. PubMed ID: 28481717
[TBL] [Abstract][Full Text] [Related]
19. New gentle-wing high-shear granulator: impact of processing variables on granules and tablets characteristics of high-drug loading formulation using design of experiment approach.
Fayed MH; Abdel-Rahman SI; Alanazi FK; Ahmed MO; Tawfeek HM; Al-Shdefat RI
Drug Dev Ind Pharm; 2017 Oct; 43(10):1584-1600. PubMed ID: 28480773
[TBL] [Abstract][Full Text] [Related]
20. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
